Results 261 to 270 of about 56,406 (298)
Some of the next articles are maybe not open access.
[Companion diagnostics and reimbursement system].
Rinsho byori. The Japanese journal of clinical pathology, 2013Recently, Companion Diagnostics (CoDx) have been gaining importance to promote personalized medicine in order to improve the safety and cost effectiveness of therapy. In July 2011, the FDA published draft guidance for the development of CoDx, which recommends the co-development of CoDx and new drugs as the best practice, and then the FDA approved ...
openaire +1 more source
[Companion Diagnostics for Solid Tumors].
Rinsho byori. The Japanese journal of clinical pathology, 2016Companion diagnostics (CoDx) will likely continue to rapidly increase in number and application to disease areas including solid tumors, for example EGFR for gefitinib and ALK fusion gene for crizotinib in non-small-cell lung cancer; KRAS against the use of cetuximab and panitumumab in colorectal cancer; HER2 for trastuzumab in breast cancer.
openaire +1 more source
Clinical advances in hematology & oncology : H&O, 2010
Robert, Becker, Elizabeth, Mansfield
openaire +1 more source
Robert, Becker, Elizabeth, Mansfield
openaire +1 more source
Evolving Japanese regulations on companion diagnostics
Nature Biotechnology, 2016Sumimasa, Nagai +8 more
openaire +2 more sources
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
Ca-A Cancer Journal for Clinicians, 2020Aaron J Grossberg +2 more
exaly